0.26Open0.26Pre Close0 Volume15 Open Interest88.00Strike Price0.00Turnover179.15%IV11.82%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.26Extrinsic Value100Contract SizeAmericanOptions Type0.0920Delta0.0263Gamma303.58Leverage Ratio-0.7045Theta0.0001Rho27.92Eff Leverage0.0058Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet